Millner F. Ann 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Jan 24, 2024
Insider Transaction Report
Form 4
Millner F. Ann
Director
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2024-01-22$34.40/sh+20,000$688,000→ 49,960 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2024-01-22−20,000→ 0 totalExercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (20,000 underlying) - Sale
Common Stock, No Par Value
2024-01-22$80.00/sh−20,000$1,600,000→ 29,960 total
Holdings
- 25,000
Non-qualified stock options (right to buy)
Exercise: $50.50From: 2019-06-07Exp: 2025-06-07→ Common Stock (25,000 underlying) - 13,750
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-24Exp: 2026-05-24→ Common Stock (13,750 underlying) - 7,500
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-31Exp: 2026-05-31→ Common Stock (7,500 underlying)
Footnotes (6)
- [F1]The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.
- [F2]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.000 to $80.035, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
- [F4]Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
- [F5]Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
- [F6]Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.